Authors: LALISANG RI WILS JA NORTIER HW BURGHOUTS JT HUPPERETS PS ERDKAMP FL SCHOUTEN HC BLIJHAM GH

Citation: Ri. Lalisang et al., COMPARATIVE-STUDY OF DOSE-ESCALATION VERSUS INTERVAL REDUCTION TO OBTAIN DOSE-INTENSIFICATION OF EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1367-1376

Authors: ERDKAMP FL SCHOUTEN HC BREED WP JANSSEN WC HOFFMANN JJ SCHUTTE B BLIJHAM GH

Citation: Fl. Erdkamp et al., DNA ANEUPLOIDY IN HODGKINS-DISEASE - A MULTIPARAMETER FLOW CYTOMETRICANALYSIS, Leukemia & lymphoma, 12(3-4), 1994, pp. 297-306

Authors: PASMAN PC TIEBOSCH A ERDKAMP FL VRINTS LW BREED WP SCHOUTEN HC

Citation: Pc. Pasman et al., P53 AS A MARKER OF THE MALIGNANT-CELL IN HODGKINS-DISEASE, Annals of oncology, 5, 1994, pp. 190000089-190000091

Authors: ERDKAMP FL SCHOUTEN HC BREED WP JANSSEN WC HOFFMANN JJ REYNDERS M SCHUTTE M BLIJHAM GH

Citation: Fl. Erdkamp et al., COMPARISON OF IMAGE (CAS-200) AND FLOW-CYTOMETRY DETERMINED DNA CONTENT OF PARAFFIN-EMBEDDED HODGKINS-DISEASE TISSUE, Hematologic pathology, 8(3), 1994, pp. 75-84